Trial Profile
Skeletal muscle-derived cell implantation in female patients with stress urinary incontinence: a multicenter, randomized, parallel-group, placebo-controlled clinical study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2022
Price :
$35
*
At a glance
- Drugs ICES 13 (Primary) ; Duloxetine
- Indications Stress incontinence
- Focus Therapeutic Use
- Acronyms SUITE
- Sponsors Innovacell Biotechnologie GmbH
- 30 Jul 2022 Status changed from recruiting to completed.
- 21 Apr 2015 New trial record